- ￥600 - 1699
- Sino Biological
- 北京
- 11085-T62
- 2025年09月19日
- WB,ELISA
- Rabbit
- H1N1
企业认证
研选同类产品更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 用户评价
- 文献和实验
- 技术资料
- 免疫原：
Recombinant Influenza H1N1 (A/California/07/2009) Hemagglutinin / HA Protein (Catalog#11085-V08H)
- 亚型：
Rabbit IgG
- 形态：
液体
- 保存条件：
-20℃ to -80℃
- 克隆性：
兔多抗
- 适应物种：
H1N1
- 保质期：
12个月
- 抗原来源：
11085-V08H
- 目录编号：
11085-T62
- 级别：
免疫学试剂
- 库存：
99
- 供应商：
北京义翘神州科技股份有限公司
- 宿主：
Rabbit
- 应用范围：
WB,ELISA
- 浓度：
WB: 1:1000-1:5000;ELISA: 1:5000-1:10000
- 靶点：
HA
- 抗体英文名：
Influenza A H1N1 (A/California/07/2009) Hemagglutinin / HA Antibody, Rabbit PAb, Antigen Affinity Purified
- 抗体名：
Influenza A H1N1 (A/California/07/2009) Hemagglutinin / HA Antibody, Rabbit PAb, Antigen Affinity Purified
- 规格：
20 µL/100 µL
| 规格： | 20 µL | 产品价格： | ￥600.0 |
|---|---|---|---|
| 规格： | 100 µL | 产品价格： | ￥1699.0 |
H1N1 HA|H1N1 HA antibody|H1N1 HA抗体|抗-H1N1 HA 兔抗体（产品说明）
抗体种属：H1N1
抗体靶点：HA
抗体应用：WB,ELISA
抗原货号：11085-V08H
抗原描述：Recombinant Influenza H1N1 (A/California/07/2009) Hemagglutinin / HA Protein (Catalog#11085-V08H)
抗体宿主：Rabbit
抗体Ig类型：Rabbit IgG
抗体纯化方法：Protein A & Antigen Affinity
抗体制备：Produced in rabbits immunized with purified, recombinant Influenza H1N1 (A/California/07/2009) Hemagglutinin / HA ( Catalog#11085-V08H; ACP41953.1; Met1-Gln529). Influenza H1N1 (A/California/07/2009) Hemagglutinin / HA specific IgG was purified by Influenza H1N1 (A/California/07/2009) Hemagglutinin / HA affinity chromatography.
抗体特异性：Influenza H1N1 (A/California/07/2009) Hemagglutinin / HA
抗体保存：This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
用户评价
暂无用户评价
文献和实验1, Schwerdtner M, et al. Expression of TMPRSS2 is up-regulated by bacterial flagellin, LPS, and Pam3Cys in human airway cells.Life science alliance, PubMed ID: 37208193
2, Heindl MR, et al. ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells.Journal of virology, PubMed ID: 38470058
3, Tang P, et al. A ferritin nanoparticle vaccine based on the hemagglutinin extracellular domain of swine influenza A (H1N1) virus elicits protective immune responses in mice and pigs.Frontiers in immunology, PubMed ID: 38835763
PCR for the Detection of Influenza Viruses in Clinical Material
). Influenza A viruses are further divided into subtypes H1N1, H2N2 and H3N2, based on differences in the hemagglutinin (HA) and neuraminidase (NA) genes. The ability of influenza viruses to undergo antigenic change in HA and NA enables the virus to evade
Genetic Engineering of Live Attenuated Influenza Viruses
vaccine strain is a reassortant virus that contains the hemagglutinin (HA) and neuraminidase (NA) gene segments from a wild-type influenza virus and the six internal protein gene segments from a master donor virus (MDV) of either cold-adapted A/Ann Arbor
The Mouse as Model System to Study Host‐Pathogen Interactions in Influenza A Infections
. Sun, X., Tse, L.V., Ferguson, A.D., and Whittaker, G.R. 2010. Modifications to the hemagglutinin cleavage site control the virulence of a neurotropic H1N1 influenza virus. J. Virol. 84:8683‐8690
技术资料暂无技术资料 索取技术资料
